To propose GRK2 as a potential drug target in T2DM, it would be necessary to target organs for GRK2 and show that suppression of those GRK2 can reverse chronic endothelial dysfunction by restoring glucose homeostasis and insulin sensitivity. Here, GRK2 is linked to type 2 diabetes mellitus.